1. At last, Burkholderia spp. is one of the inclusion criteria--a negative (but published) randomised controlled trial;Balfour-Lynn;Journal of Cystic Fibrosis,2014
2. No antibiotic cross-resistance after 1 year of continuous aztreonam for inhalation solution (AZLI) in cystic fibrosis (CF) patients (pts) with chronic Burkholderia (BURK) infection;Burns;Journal of Cystic Fibrosis,2012
3. The effect of burkholderia colony morphology in cystic fibrosis (CF) patients with chronic burkholderia species in a randomized trial of Aztreonam For Inhalation Solution (AZLI);Burns;Pediatric Pulmonology,2012
4. EUCTR2009-011740-19-Outside-EU/EEA Clinical trial to assess the safety and efficacy of aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF) and chronic burkholderia species infection www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-011740-19-Outside-EU/EEA
5. NCT01059565 Safety and efficacy study of aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis and chronic burkholderia species infection https://clinicaltrials.gov/show/nct01059565